Summit Therapeutics to Report Financial Results for the First Quarter Ended 30 April 2016 on 2 June 2016

Go back to Summit Therapeutics to Report Financial Results for the First Quarter Ended 30 April 2016 on 2 June 2016

Summit Therapeutics (SMMT) Reports Q1 Loss of GBP0.09/Share

June 2, 2016 7:08 AM EDT

Summit Therapeutics (NASDAQ: SMMT) reported Q1 EPS of (GBP0.09), versus (GBP0.06) reported last year.

For earnings history and earnings-related data on Summit Therapeutics (SMMT) click here.

... More